Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Peak Fintech Receives Approval for Common Shares to Begin Trading on NASDAQ
Published: 2021-09-07 (Crawled : 20:00) - prnewswire.com
PKKFF | $0.0723 55.09% 15K
|
Communications
| Email alert
Add to watchlist
approval nasdaq
MEDIA ADVISORY: Ultragenyx Canada Announces Health Canada Approval of a Second Indication for Crysvita™ (Burosumab Injection) for the Treatment of Tumour Induced Osteomalacia in Adults
Published: 2021-09-07 (Crawled : 12:15) - globenewswire.com
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
|
| O: 1.8%
H: 1.99%
C: -0.35%
canada approval media treatment injection approval
TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
Published: 2021-09-07 (Crawled : 12:00) - biospace.com/
TMDX M | $90.63 4.76% 4.55% 590K
|
Health Technology
|
| O: 5.94%
H: 1.96%
C: -8.12%
fda heart fda approval approval
Red White & Bloom Brands Receives Final Approval in Michigan to Move Forward with full Business Plan in the State
Published: 2021-09-07 (Crawled : 12:00) - globenewswire.com
RWBYF | $0.0279 159.86% 60K
|
Finance
| Email alert
Add to watchlist
brands approval
Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
Published: 2021-09-03 (Crawled : 16:00) - biospace.com/
GKOS | $101.1 2.17% 0.0% 350K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.19%
approval submission application
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
Published: 2021-09-03 (Crawled : 13:00) - globenewswire.com
IMPL 4 | $0.2411 -77.19% 860K
|
Professional, Scientific, and T...
|
| O: 46.24%
H: 2.78%
C: -44.84%
nasal spray treatment fda migraine fda approval approval
Codorus Valley Bancorp, Inc. Approves New Share Repurchase Program
Published: 2021-09-02 (Crawled : 21:00) - globenewswire.com
CVLY | $22.21 -0.45% -0.45% 11K
|
Finance
|
| O: 1.0%
H: 0.0%
C: -0.49%
approval program
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals
Published: 2021-09-02 (Crawled : 15:15) - fda.gov
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
fda therapy drug approval fda ide milestone
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden
Published: 2021-09-02 (Crawled : 14:00) - globenewswire.com
ATOS | $1.485 4.58% 4.38% 1.1M
|
Health Technology
|
| O: 0.27%
H: 14.33%
C: 0.8%
phase 2 approval authorized
Regal Beloit Shareholders Approve Share Issuance Necessary For Combination With Rexnord PMC; Shareholders Also Approve Name Change And Increase In Authorized Shares
Published: 2021-09-01 (Crawled : 15:00) - prnewswire.com
RBC A | $245.92 0.66% -1.59% 220K
|
Producer Manufacturing
|
| O: 0.21%
H: 0.31%
C: -1.36%
approval authorized
Janssen Announces U.S. FDA Approval of INVEGA HAFYERA™ (6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
Published: 2021-09-01 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.13%
H: 0.49%
C: 0.49%
treatment fda schizophrenia fda approval approval
VAALCO Announces Etame Co-Venturers Approve FSO Agreements
Published: 2021-08-31 (Crawled : 21:00) - globenewswire.com
EGY | $6.43 -3.31% 0.0% 1.1M
|
Energy Minerals
|
| O: 2.04%
H: 0.8%
C: 0.0%
approval
Orezone Announces Overwhelming Support for Approval of Resolutions at Special Shareholder Meeting
Published: 2021-08-31 (Crawled : 17:00) - globenewswire.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
| Email alert
Add to watchlist
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
| Email alert
Add to watchlist
approval
Medivir receives regulatory approval from MHRA for phase 1/2a combination study with MIV-818
Published: 2021-08-31 (Crawled : 08:00) - prnewswire.com
IGMS | $7.73 14.52% 12.68% 410K
|
Health Technology
|
| O: 0.37%
H: 1.35%
C: -2.63%
phase 1 approval phase 2 phase 3
Ligand’s Partner Gloria Biosciences Receives Approval in China for Zimberelimab for the Treatment of Recurrent or Refractory Classical Hodgkin’s Lymphoma
Published: 2021-08-30 (Crawled : 21:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
LGND | $69.97 2.1% 2.06% 140K
|
Health Technology
|
| O: 0.65%
H: 5.84%
C: 5.28%
treatment china approval
SYNNEX Corporation Announces Receipt of All Required Regulatory Approvals for Pending Merger with Tech Data
Published: 2021-08-27 (Crawled : 13:00) - prnewswire.com
SNX 4 | $115.94 0.93% 0.0% 490K
|
Distribution Services
|
| O: 0.06%
H: 1.52%
C: 0.63%
merge approval
Incyte and MorphoSys Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-08-26 (Crawled : 21:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.28%
H: 0.89%
C: -2.02%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.49%
H: 1.34%
C: -0.42%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.25%
H: 0.33%
C: -1.05%
treatment europe approval t-cell
Atlanticus Announces Approval of Quarterly Preferred Stock Dividend
Published: 2021-08-26 (Crawled : 21:00) - globenewswire.com
ATLC | $24.375 3.95% 3.79% 15K
|
Finance
|
| O: 0.3%
H: 8.02%
C: 7.45%
approval
Greenlane Shareholders Vote to Approve Merger with KushCo
Published: 2021-08-26 (Crawled : 21:00) - globenewswire.com
GNLN | $0.5801 -4.1% -4.28% 290K
|
Distribution Services
|
| O: 0.82%
H: 7.76%
C: 6.12%
merge approval
Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label
Published: 2021-08-26 (Crawled : 12:00) - biospace.com/
IRWD | $8.305 3.04% 2.95% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.38%
C: -0.31%
fda fda approval approval
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.